Cargando…
GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome
BACKGROUND: The complex pathophysiology of epilepsy hampers the development of effective treatments. Although more than ten kinds of anti-seizures drugs (ASDs) have good effects on seizure control worldwide, about 30% of patients still display pharmacoresistance against ASDs. Neuroinflammation seems...
Autores principales: | Qin, Zhangjin, Song, Jiaqi, Lin, Aolei, Yang, Wei, Zhang, Wenbo, Zhong, Fuxin, Huang, Lihong, Lü, Yang, Yu, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137133/ https://www.ncbi.nlm.nih.gov/pubmed/35624482 http://dx.doi.org/10.1186/s12974-022-02482-2 |
Ejemplares similares
-
The inhibition of PGAM5 suppresses seizures in a kainate-induced epilepsy model via mitophagy reduction
por: Zhong, Fuxin, et al.
Publicado: (2022) -
GPR40 modulates epileptic seizure and NMDA receptor function
por: Yang, Yong, et al.
Publicado: (2018) -
DHA/AA alleviates LPS-induced Kupffer cells pyroptosis via GPR120 interaction with NLRP3 to inhibit inflammasome complexes assembly
por: Fan, Guoqiang, et al.
Publicado: (2021) -
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models
por: Palumbo, Laura, et al.
Publicado: (2023) -
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
por: Han, Qiu-Qin, et al.
Publicado: (2023)